PF-07209326
/ Pfizer
- LARVOL DELTA
Home
Next
Prev
1 to 6
Of
6
Go to page
1
August 02, 2023
Dose Escalation Study of PF-07209326 in Healthy Participants and Participants With Sickle Cell Disease
(clinicaltrials.gov)
- P1 | N=52 | Completed | Sponsor: Pfizer | Active, not recruiting ➔ Completed
Trial completion • Anemia • Genetic Disorders • Hematological Disorders • Sickle Cell Disease
April 21, 2023
Dose Escalation Study of PF-07209326 in Healthy Participants and Participants With Sickle Cell Disease
(clinicaltrials.gov)
- P1 | N=50 | Active, not recruiting | Sponsor: Pfizer | Recruiting ➔ Active, not recruiting
Enrollment closed • Anemia • Genetic Disorders • Hematological Disorders • Sickle Cell Disease
January 24, 2022
Dose Escalation Study of PF-07209326 in Healthy Participants and Participants With Sickle Cell Disease
(clinicaltrials.gov)
- P1; N=54; Recruiting; Sponsor: Pfizer; Active, not recruiting ➔ Recruiting; Trial completion date: Feb 2022 ➔ Aug 2022; Trial primary completion date: Feb 2022 ➔ Aug 2022
Enrollment open • Trial completion date • Trial primary completion date • Anemia • Genetic Disorders • Hematological Disorders • Sickle Cell Disease • PCR
August 12, 2021
Dose Escalation Study of PF-07209326 in Healthy Participants and Participants With Sickle Cell Disease
(clinicaltrials.gov)
- P1; N=54; Active, not recruiting; Sponsor: Pfizer; Recruiting ➔ Active, not recruiting
Enrollment closed • Anemia • Genetic Disorders • Hematological Disorders • Sickle Cell Disease • PCR
May 12, 2021
Dose Escalation Study of PF-07209326 in Healthy Participants
(clinicaltrials.gov)
- P1; N=54; Recruiting; Sponsor: Pfizer; Trial completion date: Jul 2021 ➔ Feb 2022; Trial primary completion date: Jul 2021 ➔ Feb 2022
Clinical • Trial completion date • Trial primary completion date • Genetic Disorders • Hematological Disorders • Sickle Cell Disease
February 04, 2021
Dose Escalation Study of PF-07209326 in Healthy Participants
(clinicaltrials.gov)
- P1; N=60; Recruiting; Sponsor: Pfizer; Trial completion date: Mar 2021 ➔ Jul 2021; Trial primary completion date: Mar 2021 ➔ Jul 2021
Clinical • Trial completion date • Trial primary completion date
1 to 6
Of
6
Go to page
1